Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Clay Siegall, PhD, President and CEO of Immunome, will...

Related Keywords

Clay Siegall , Nasdaq , Health Care Conference On , Immunome Inc , Twitter , Linkedin , Annual Health Care Conference , Investor Relations ,